13F filing recap · Q4 2013
What did Maverick Capital buy in Q4 2013?
Reported stock-position changes between this filing and the previous one.
Stock value
$7.74B
Positions
64
Estimated turnover
85.7%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
EBAYEbay Inc.$314.24Mreported value+5.73M sharesVRXValeant Pharmaceuticals International, Inc.$191.81Mreported value+1.63M sharesCTRXCatamaran Corporation$190.25Mreported value+4.01M sharesCPNCalpine Corp$183.75Mreported value+9.42M sharesFFIVF5, Inc.$131.58Mreported value+1.45M sharesAVGOBroadcom Inc.$124.72Mreported value+2.36M sharesBIDUBaidu, Inc.$123.70Mreported value+695.4K sharesABEVAmbev S.a.$105.61Mreported value+14.37M sharesYHOOAltaba Inc.$102.53Mreported value+2.54M sharesHUMHumana Inc$85.99Mreported value+833.0K sharesCIThe Cigna Group$80.27Mreported value+917.5K sharesPNRAPanera Bread Co$49.59Mreported value+280.6K sharesTWCTime Warner Cable Inc$47.60Mreported value+351.3K sharesULTAUlta Beauty, Inc.$43.35Mreported value+449.1K sharesVISNCommscope Holding Company, Inc.$41.56Mreported value+2.20M sharesISRGIntuitive Surgical, Inc.$35.14Mreported value+91.5K sharesCQHCheniere Energy Partners LP Holdings LLC$32.77Mreported value+1.75M sharesASMLAsml Holding N.v.$20.15Mreported value+215.0K sharesESNTEssent Group Ltd.$7.22Mreported value+300.0K shares